Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease

NCT03854019 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Huntington Disease
Irritability

Interventions

DRUG: Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)
DRUG: Placebo

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]